Validation of the cultural adaptation of the "Long Coronavirus Disease (COVID) Symptom and Impact Tools" for the Chilean population.

IF 0.8 Q2 MEDICINE, GENERAL & INTERNAL
Vivienne C Bachelet, Rosa Jiménez-Paneque, Patricio Gomolán, Ignacio Silva-Ayarza, Mercedes López Nitsche, Catalina O Andrades, Belén Carroza, Bruno Morgado
{"title":"Validation of the cultural adaptation of the \"Long Coronavirus Disease (COVID) Symptom and Impact Tools\" for the Chilean population.","authors":"Vivienne C Bachelet, Rosa Jiménez-Paneque, Patricio Gomolán, Ignacio Silva-Ayarza, Mercedes López Nitsche, Catalina O Andrades, Belén Carroza, Bruno Morgado","doi":"10.5867/medwave.2026.02.3205","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The Long Coronavirus Disease (COVID) Symptom and Impact Tools (ST and IT) are self-administered instruments designed to monitor symptoms and the impact of long COVID. We translated and culturally adapted these tools for use in Chile. This study evaluated internal consistency and test-retest reliability for the IT, described reported symptoms with the ST, and explored changes over time.</p><p><strong>Methods: </strong>The first phase, previously published, involved translation and cultural adaptation. The second phase included 28 patients with persistent COVID-19 symptoms; 20 completed a second assessment. The IT assesses impact using six items, each scored 0-10 (total 0-60). The ST lists 53 symptoms across ten categories. Internal consistency of the IT was assessed using Cronbach's alpha and item-consistency indicators. Test-retest reliability was evaluated using the intraclass correlation coefficient (ICC, 95% CI) and a Bland-Altman analysis. ST responses were summarized with absolute and relative frequencies and confidence intervals.</p><p><strong>Results: </strong>The IT showed excellent internal consistency (Cronbach's alpha 0.945; 95% CI 0.906-0.971). Test-retest reliability was acceptable (ICC 0.72; 95% CI 0.43-0.88), with minimal bias in the Bland-Altman plot. General, neurological, thoracic, and ear-nose-throat symptoms were the most frequent. Participants reported a mean of 19 symptoms, with no significant differences between visits.</p><p><strong>Conclusions: </strong>The adapted tools demonstrated acceptable psychometric properties and appear suitable for use in Chile. Symptom reporting was extensive, underscoring the need for larger studies to confirm these findings.</p>","PeriodicalId":18597,"journal":{"name":"Medwave","volume":"26 2","pages":"e3205"},"PeriodicalIF":0.8000,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medwave","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5867/medwave.2026.02.3205","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The Long Coronavirus Disease (COVID) Symptom and Impact Tools (ST and IT) are self-administered instruments designed to monitor symptoms and the impact of long COVID. We translated and culturally adapted these tools for use in Chile. This study evaluated internal consistency and test-retest reliability for the IT, described reported symptoms with the ST, and explored changes over time.

Methods: The first phase, previously published, involved translation and cultural adaptation. The second phase included 28 patients with persistent COVID-19 symptoms; 20 completed a second assessment. The IT assesses impact using six items, each scored 0-10 (total 0-60). The ST lists 53 symptoms across ten categories. Internal consistency of the IT was assessed using Cronbach's alpha and item-consistency indicators. Test-retest reliability was evaluated using the intraclass correlation coefficient (ICC, 95% CI) and a Bland-Altman analysis. ST responses were summarized with absolute and relative frequencies and confidence intervals.

Results: The IT showed excellent internal consistency (Cronbach's alpha 0.945; 95% CI 0.906-0.971). Test-retest reliability was acceptable (ICC 0.72; 95% CI 0.43-0.88), with minimal bias in the Bland-Altman plot. General, neurological, thoracic, and ear-nose-throat symptoms were the most frequent. Participants reported a mean of 19 symptoms, with no significant differences between visits.

Conclusions: The adapted tools demonstrated acceptable psychometric properties and appear suitable for use in Chile. Symptom reporting was extensive, underscoring the need for larger studies to confirm these findings.

智利人群“长冠状病毒病(COVID)症状和影响工具”的文化适应性验证。
长冠状病毒病(COVID)症状和影响工具(ST和IT)是自我管理的工具,旨在监测长冠状病毒病的症状和影响。我们对这些工具进行了翻译和文化调整,以便在智利使用。本研究评估了IT的内部一致性和重测可靠性,描述了ST的报告症状,并探讨了随时间的变化。方法:第一阶段,先前发表,涉及翻译和文化适应。第二阶段纳入28例持续出现COVID-19症状的患者;20人完成了第二次评估。IT使用6个项目评估影响,每个项目得分0-10(总分0-60)。ST列出了10个类别的53种症状。使用Cronbach's alpha和项目一致性指标评估IT的内部一致性。采用类内相关系数(ICC, 95% CI)和Bland-Altman分析评估重测信度。ST反应用绝对频率和相对频率以及置信区间进行总结。结果:IT具有良好的内部一致性(Cronbach's alpha 0.945; 95% CI 0.906-0.971)。重测信度可接受(ICC 0.72; 95% CI 0.43-0.88), Bland-Altman图偏差最小。一般症状、神经症状、胸廓症状和耳鼻喉症状最为常见。参与者平均报告了19种症状,两次访问之间没有显着差异。结论:适应的工具表现出可接受的心理测量特性,似乎适合在智利使用。症状报告是广泛的,强调需要更大规模的研究来证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medwave
Medwave MEDICINE, GENERAL & INTERNAL-
CiteScore
2.60
自引率
8.30%
发文量
50
审稿时长
12 weeks
期刊介绍: Medwave is a peer-reviewed, biomedical and public health journal. Since its foundation in 2001 (Volume 1) it has always been an online only, open access publication that does not charge subscription or reader fees. Since January 2011 (Volume 11, Number 1), all articles are peer-reviewed. Without losing sight of the importance of evidence-based approach and methodological soundness, the journal accepts for publication articles that focus on providing updates for clinical practice, review and analysis articles on topics such as ethics, public health and health policy; clinical, social and economic health determinants; clinical and health research findings from all of the major disciplines of medicine, medical science and public health. The journal does not publish basic science manuscripts or experiments conducted on animals. Until March 2013, Medwave was publishing 11-12 numbers a year. Each issue would be posted on the homepage on day 1 of each month, except for Chile’s summer holiday when the issue would cover two months. Starting from April 2013, Medwave adopted the continuous mode of publication, which means that the copyedited accepted articles are posted on the journal’s homepage as they are ready. They are then collated in the respective issue and included in the Past Issues section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书